Skip to main content

Table 3 Effects of silymarin on H-MDA, H-GSH and Plasma TAC

From: Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats

GROUP H-MDA (nmol/g tissue) H-GSH (μmol/g tissue) P-TAC (nmol AAEAC/L)
NC 52.65 ± 3.49 37.98 ± 1.07 0.933 ± 0.001
FC 67.60 ± 3.21*** 33.93 ± 0.91*** 0.927 ± 0.002***
SC 56.21 ± 4.99 ## 36.53 ± 0.89 ## 0.931 ± 0.002 ##
FTH 59.77 ± 5.40 # 35.49 ± 0.98 0.930 ± 0.002 #
FFH 57.63 ± 4.48 ## 36.35 ± 0.93 ## 0.930 ± 0.001#
  1. At the end of the experiment the H-MDA, H-GSH and Plasma TAC were measured. NC normal control, FC fructose control, SC silymarin control, FTH fructose + 200 mg/kg silymarin, FFH fructose + 400 mg/kg silymarin. Data were presented as mean ± SD. N = 6 for each group. *** p < 0.001 vs. NC and # p < 0.05 vs. FC; ## p < 0.01 vs. FC